YJ001 spray for diabetic nerve pain in the feet
This trial tests a spray called YJ001 for pain in the feet caused by diabetic nerve damage. It aims to see if the spray can reduce pain better than a placebo, and may offer a new way to manage this type of pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had type 1 or type 2 diabetes for at least a year.
- You have had nerve pain in your feet for at least 6 months, and this pain is the most painful area.
- Your blood sugar control has been stable for the last 3 months, with a recent blood test (HbA1c) at 9.0% or lower.
- Your average pain score is at least 4 out of 10 (moderate to severe) but less than 9.
- You have not used certain pain medications (like pregabalin, gabapentin, duloxetine, or strong painkillers) within a few days to weeks before starting, depending on the drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This study tests a new spray medication (YJ001) applied to the feet to see if it is safe and helps reduce pain in people with diabetic peripheral neuropathy. You may qualify if you have diabetes, stable blood sugar, and moderate to severe nerve pain in your feet.
This study tests an investigational medicine (HL-1186) to see if it can reduce nerve pain caused by diabetes. If you have had burning or shooting pain in your feet or legs for at least 6 months, this trial might help find a new way to ease that pain.
This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.
This trial tests a capsule (DLBS1033) to see if it can relieve pain and improve nerve function in people with diabetic polyneuropathy. It may help reduce the numbness or tingling caused by long-term diabetes.
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Hear when a new Diabetic Peripheral Neuropathic Pain (DPNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.